A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer

2019 ◽  
Vol 10 (6) ◽  
pp. 847-858 ◽  
Author(s):  
Inez Charlotte van Walree ◽  
Ellen Scheepers ◽  
Lieke van Huis-Tanja ◽  
Marielle H. Emmelot-Vonk ◽  
Carine Bellera ◽  
...  
2019 ◽  
Vol 10 (6) ◽  
pp. 859-873 ◽  
Author(s):  
Cheryl P. Bruijnen ◽  
Diny G. van Harten-Krouwel ◽  
José J. Koldenhof ◽  
Mariëlle H. Emmelot-Vonk ◽  
Petronella O. Witteveen

2015 ◽  
Vol 6 (3) ◽  
pp. 185-193 ◽  
Author(s):  
Roopa Lakhanpal ◽  
Jaclyn Yoong ◽  
Sachin Joshi ◽  
Desmond Yip ◽  
Linda Mileshkin ◽  
...  

2018 ◽  
Vol 14 (2) ◽  
pp. 85-94 ◽  
Author(s):  
Kah Poh Loh ◽  
Enrique Soto-Perez-de-Celis ◽  
Tina Hsu ◽  
Nienke A. de Glas ◽  
Nicolò Matteo Luca Battisti ◽  
...  

Aging is a heterogeneous process. Most newly diagnosed cancers occur in older adults, and it is important to understand a patient’s underlying health status when making treatment decisions. A geriatric assessment provides a detailed evaluation of medical, psychosocial, and functional problems in older patients with cancer. Specifically, it can identify areas of vulnerability, predict survival and toxicity, assist in clinical treatment decisions, and guide interventions in routine oncology practice; however, the uptake is hampered by limitations in both time and resources, as well as by a lack of expert interpretation. In this review, we describe the utility of geriatric assessment by using an illustrative case and provide a practical approach to geriatric assessment in oncology.


2007 ◽  
Vol 25 (14) ◽  
pp. 1824-1831 ◽  
Author(s):  
Martine Extermann ◽  
Arti Hurria

Purpose During the last decade, oncologists and geriatricians have begun to work together to integrate the principles of geriatrics into oncology care. The increasing use of a comprehensive geriatric assessment (CGA) is one example of this effort. A CGA includes an evaluation of an older individual's functional status, comorbid medical conditions, cognition, nutritional status, psychological state, and social support; and a review of the patient's medications. This article discusses recent advances on the use of a CGA in older patients with cancer. Methods In this article, we provide an update on the studies that address the domains of a geriatric assessment applied to the oncology patient, review the results of the first studies evaluating the use of a CGA in developing interventions to improve the care of older adults with cancer, and discuss future research directions. Results The evidence from recent studies demonstrates that a CGA can predict morbidity and mortality in older patients with cancer. Accumulating data show the benefits of incorporating a CGA in the evaluation of older patients with cancer. Prospective trials evaluating the utility of a CGA to guide interventions to improve the quality of cancer care in older adults are justified. Conclusion Growing evidence demonstrates that the variables examined in a CGA can predict morbidity and mortality in older patients with cancer, and uncover problems relevant to cancer care that would otherwise go unrecognized.


2021 ◽  
Vol 12 (1) ◽  
pp. 49-56
Author(s):  
Kathelijn S. Versteeg ◽  
Stéphanie M.L.M. Looijaard ◽  
Monique S. Slee-Valentijn ◽  
Henk M.W. Verheul ◽  
Andrea B. Maier ◽  
...  

2015 ◽  
Vol 25 (1) ◽  
pp. 104-111 ◽  
Author(s):  
Florence Canoui-Poitrine ◽  
Nicoleta Reinald ◽  
Marie Laurent ◽  
Esther Guery ◽  
Philippe Caillet ◽  
...  

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 19651-19651
Author(s):  
M. Molina-Garrido ◽  
C. Guillén-Ponce ◽  
A. Carrato

19651 Background: Age is the major risk factor for the majority of patients with cancer. More than 50% of cancers occurs after the age of 60. Older patients are not simply old, but are geriatric patients because of interacting psychosocial and physical problems. As a consequence, the health status of old persons cannot be evaluated by merely describing the single disease or the group of age. We tested the performance of a new Comprehensive Geriatric Assessment (CGA) and its relationship with groups of age in cancer patients. Methods: Between June 2006 and December 2006, a total of 64 oncologic patients older than 75 years were approached to enrol in our study to analyze their functional, physical, mental, pharmacotherapeutic and socio-economic status and to correlate them to some groups of age: youngest-old (75 to 80 years-old), old-old (80 and 85 years-old) and oldest-old (older than 85 years). They were analysed Activities of Daily Living (ADL) measured by Barthel Scale, Instrumental Activities of Daily Living (IADL) measured by Lawton-Brody Scale, Grade of Fragility measured by Barber Scale, cognitive evaluation measured by Pfeiffer Test, and medication intake. A Chi Squared test was used for statistical analysis; p-value <0,05 was considered significative. Results: Sixty-four oncologic patients age > or = 75 years were recruited. Median age was 80.24 years (range 73.88 to 86.94). 51.6% female. Breast cancer was the most frequent diagnosis (30.2%), followed by lung cancer (19%). 29 patients (45.3%) were aged between 75 and 80 years old; 27 patients (43.5%) were between 80 and 85 years- old. There were statistic significative association between groups of age and Pfeiffer Test (p=0.037), Barber Scale (p=0.031) and medication intake (p=0.021). However, there was not a significative relationship between groups of age and Barthel Scale (p=0.052), Lawton-Brody Scale (p=0.2425), Cruz-Roja Scale (p=0,1485) or number of geriatric syndromes (p=0.129). Conclusions: This abstract reviews the findings regarding the correlation between a comprehensive geriatric assessment (CGA) and groups of age in older patients with cancer. Age per se must not be the only criterion for medical decision as it is not correlated to the health status of older cancer patients. No significant financial relationships to disclose.


Sign in / Sign up

Export Citation Format

Share Document